GlassScriptPhysician profile
Matvey Pinkusovich
NPI 1659341618
$384.70
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.88 · 2020: $139 · 2021: $128 · 2022: $58.18.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $93.19 | 2020-2022 | |
| Hologic Sales and Service, LLC | $58.88 | 2019 | |
| Endo Pharmaceuticals INC. | $46.31 | 2020 | |
| Ironwood Pharmaceuticals, INC | $37.70 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $37.67 | 2020 | |
| Vivus LLC | $36.68 | 2021 | |
| Nestle Healthcare Nutrition INC. | $23.03 | 2022 | |
| Arbor Pharmaceuticals, INC. | $20.00 | 2021 | |
| Abbvie INC. | $15.78 | 2021 | |
| Lilly USA, LLC | $15.46 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matvey Pinkusovich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.